Justices Must Resolve Off-Label Drug Warning Predicament
The U.S. Supreme Court will soon decide whether to hear a case, Janssen Pharmaceuticals Inc. v. AY, involving the off-label use of drugs approved by the U.S. Food and Drug Administration....To view the full article, register now.
Already a subscriber? Click here to view full article